VERTEX PHARMACEUTICALS INC / MA business relationships
Companies named in VERTEX PHARMACEUTICALS INC / MA’s 10-K filed 2026-02-13, and public companies whose annual reports name VERTEX PHARMACEUTICALS INC / MA. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 70 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in VERTEX PHARMACEUTICALS INC / MA’s annual report 3
“In 2016, we entered into a strategic collaboration and licensing agreement with Moderna, Inc. ("Moderna"), pursuant to” SEC filing
“• Moderna, Inc. In 2016, we entered into a collaboration with Moderna for the identification and development of” SEC filing
“• Entrada Therapeutics, Inc. In 2022, we established a collaboration with Entrada focused on enabling efficient” SEC filing
Links are read automatically from public company filings, so every link carries the sentence it came from.
Not investment advice. Scores, rankings and connections are automated estimates from public sources, provided as is. Connections are read automatically from public company filings and may be incomplete or wrong. To correct or remove a company page or a connection, email [email protected]. Company names and logos belong to their owners. Showing them does not mean the company endorses Engagemii or that Engagemii endorses it. Terms